Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Viking Thera (NQ: VKTX ) 64.67 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Apr 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,380 Open 64.67 Bid (Size) 64.06 (2) Ask (Size) 67.28 (1) Prev. Close 64.67 Today's Range 64.67 - 64.67 52wk Range 8.280 - 99.41 Shares Outstanding 99,581,693 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Market Whales and Their Recent Bets on VKTX Options April 18, 2024 Via Benzinga These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come? April 16, 2024 These three biotech stocks are leading the sector higher on upbeat news but is this as good as it gets or do they have more gas in the tank? Via InvestorPlace Performance YTD +253.77% +253.77% 1 Month -0.78% -0.78% 3 Month +208.83% +208.83% 6 Month +540.30% +540.30% 1 Year +204.04% +204.04% More News Read More $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today April 15, 2024 Via Benzinga Viking Therapeutics: Strong Results In Obesity April 13, 2024 Via Talk Markets 3 Magnificent Stocks That Could Double or More by 2030 April 13, 2024 Via The Motley Fool Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027 April 12, 2024 Via InvestorPlace Viking Therapeutics's Options: A Look at What the Big Money is Thinking April 09, 2024 Via Benzinga Is it Too Late to Buy Viking Therapeutics Stock? April 06, 2024 Via The Motley Fool Viking Therapeutics Just Announced More Positive Results: Time to Buy? April 04, 2024 Via The Motley Fool If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names April 11, 2024 Via InvestorPlace Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics April 09, 2024 Via The Motley Fool Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead. April 09, 2024 Via The Motley Fool Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out? April 09, 2024 Via MarketBeat Exposures Product Safety Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It. April 08, 2024 Via The Motley Fool $1000 Invested In This Stock 5 Years Ago Would Be Worth $6,900 Today April 02, 2024 Via Benzinga MarketBeat Week in Review – 4/1 - 4/5 April 06, 2024 Via MarketBeat Topics Economy Exposures Interest Rates Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics April 05, 2024 Via The Motley Fool 10 Health Care Stocks Whale Activity In Today's Session April 04, 2024 Via Benzinga 1 Brand-New (Good) Reason to Buy Viking Therapeutics Stock Now April 04, 2024 Via The Motley Fool 2 Potentially Explosive Stocks to Buy in April April 04, 2024 Via The Motley Fool Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market? April 04, 2024 Via The Motley Fool 10 Health Care Stocks Whale Activity In Today's Session April 03, 2024 Via Benzinga Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill April 03, 2024 Via MarketBeat Exposures Product Safety 5 Healthcare Stocks to Buy for 2024 April 02, 2024 Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts April 02, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.